Technology | April 01, 2009

Mortara Introduces Wireless ECG Technology Platform

April 1, 2009 - Mortara Instrument unveiled its new go wireless technology platform with the introduction of its Wireless Acquisition Module (WAM) for resting ECG and the T12 transmitter for wireless stress exercise testing.

The go wireless platform is comprised of proprietary Mortara technology that is specifically designed to offer an equivalent or lower cost alternative to wired designs in ECG applications. The go wireless technology is optimized for diagnostic ECG acquisition with simple configuration, long battery life, and robust transmission protocols to be integrated into a wide array of ECG acquisition products.

The wireless acquisition module (WAM) is the first go wireless product for resting ECG acquisition to be introduced. The WAM is a high-fidelity diagnostic ECG acquisition module with integrated go wireless capabilities enabling transmission to Mortara ELITM electrocardiographs. At the touch of a button an ECG can be acquired or rhythm strip initiated. The wireless capability eliminates the traditional expensive and bulky ECG cable and allows caregivers greater freedom of movement while acquiring electrocardiograms.

Built upon the go wireless technology, the WAM is targeted to simply replace traditional patient cable designs. The company said the wireless technology offers a cost-effective improvement over traditional patient cables and offers patients freedom of movement to help ease ECG acquisition and improve workflow.

In addition to the WAM, Mortara Instrument also introduced its T12 transmitter for wireless stress exercise testing. The T12 transmitter, in conjunction with the X-Scribe Stress Exercise System, enables stress test procedures to be performed without the traditional bulky patient cable tethering the patient to the exercise system. Built upon the same go wireless technology platform, it is likewise designed to meet the price of traditional, wired solutions.

For more information: www.mortara.com

Related Content

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Heart Test Laboratories, HTL, MyoVista ECG, common stock offering
News | ECG | January 31, 2017
Heart Test Laboratories Inc. (HTL) has successfully raised $12 million by way of a Common Stock private placement...
AirStrip One, ECG management, web client, U.S. clearance
Technology | ECG | October 11, 2016
The U.S. Food and Drug Administration (FDA) has issued 510(K) Class II clearance to a web client for the AirStrip One...
Carestream, Vue Motion universal viewer, ECG waveforms, diagnostic reading, FDA clearance

Image courtesy of Carestream Health

Technology | ECG | November 20, 2015
Carestream has obtained U.S. Food and Drug Administration (FDA) clearance for diagnostic reading of electrocardiogram (...
CardioSecur mobile ECG, 22-lead, 360 degree view of the heart, CardioSecur Pro

Image courtesy of CardioSecur

Technology | ECG | October 08, 2015
Personal MedSystems introduced the first and only 22-lead mobile electrocardiogram (ECG) system, CardioSecur, at the...
Overlay Init